Patients Journey Before Early Rheumatoid Arthritis Diagnosis Contributes to disease's Activity Level
- 1 July 2024
- journal article
- research article
- Published by Wolters Kluwer Health in JCR: Journal of Clinical Rheumatology
- Vol. 30 (5) , e133-e139
Abstract
Introduction: The help-seeking process in rheumatoid arthritis (RA) patients is challenging, and its study is limited in Latin America. The study describes the real-life journey before patients' incorporation into an early arthritis clinic (EAC) and its impact on baseline and 1-year cumulative disease activity levels. Patients and Methods: The patient's journey was assessed through a questionnaire that captured the patient's path from the first disease-related symptom to the initial assessment in the EAC. A disease activity (28 joints evaluated)–erythrocyte sedimentation rate (DAS28-ESR) score >5.1 defined a high-disease activity level. The mean of individual consecutive DAS28-ESR scores summarized cumulative DAS28-ESR. Multiple logistic regression analysis identified factors associated with a DAS28-ESR score >5.1 at the first assessment. Linear regression analysis assessed the impact of general practitioner (GP)–first consultant and time on disease-modifying antirheumatic drugs (DMARDs) on baseline and cumulative DAS28-ESR scores. Results: Through January 2023, the EAC had 241 RA patients, among whom 209 (86.7%) completed the patients' journey questionnaire (PJQ) and 176 (84.2%) at least 1 year of follow-up. A GP was the first consultant in 76.6% of the patients, and only 12.4% were prescribed DMARDs. Patients had additional evaluations with either rheumatologists (38.6%) or other specialists (31.6%), and half of them were initiated DMARDs. GP-first consultant (adjusted odds ratio: 2.314, 95% confidence interval: 1.190–4.500, p = 0.013) and time on DMARDs (adjusted odds ratio: 0.738, 95% confidence interval: 0.585–0.929, p = 0.010) were associated with baseline DAS28-ESR score >5.1. The B coefficient magnitudes for GP-first consultant and time on DMARDs to predict cumulative DAS28 progressively decreased during the first year of follow-up. Conclusions: Patients' journey before recent-onset RA diagnosis predicts first-year disease activity levels.Keywords
This publication has 35 references indexed in Scilit:
- Traditional and modern management strategies for rheumatoid arthritisClinica Chimica Acta, 2021
- Early clinical response and long-term radiographic progression in recent-onset rheumatoid arthritis: Clinical remission within six months remains the treatment targetJoint Bone Spine, 2019
- Taking the patient and the patient's perspective into account to improve outcomes of care of patients with musculoskeletal diseasesBest Practice & Research Clinical Rheumatology, 2019
- Predictors of treatment response in rheumatoid arthritisJoint Bone Spine, 2019
- Factors associated with time to diagnosis in early rheumatoid arthritisRheumatology International, 2013
- Patterns of Disease‐Modifying Antirheumatic Drug Use in Rheumatoid Arthritis Patients After 2002: A Systematic ReviewArthritis Care & Research, 2013
- Lag time between onset of symptoms and diagnosis in Venezuelan patients with rheumatoid arthritisRheumatology International, 2010
- Delay in consultation with specialists for persons with suspected new‐onset rheumatoid arthritis: A population‐based studyArthritis Care & Research, 2007
- Improving management of musculoskeletal disorders in primary care: the Joint Adventures ProgramClinical Rheumatology, 2006
- Gaps in care for rheumatoid arthritis: A population studyArthritis Care & Research, 2005